Rivaroxaban plus aspirin vs. dual antiplatelet therapy in endovascular treatment in peripheral artery disease and analysis of medication utilization of different lesioned vascular regions

BACKGROUND: In the management of Peripheral Arterial Disease (PAD), the administration of anticoagulant or antiplatelet agents is imperative. The use of Dual Antiplatelet Therapy (DAPT) in conjunction with rivaroxaban has shown potential in mitigating adverse outcomes. Given the heterogeneity in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, SiYan, Cheng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665835/
https://www.ncbi.nlm.nih.gov/pubmed/38026492
http://dx.doi.org/10.3389/fsurg.2023.1285553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665835/
https://www.ncbi.nlm.nih.gov/pubmed/38026492
http://dx.doi.org/10.3389/fsurg.2023.1285553

Ejemplares similares